Synthesis and Extraction Processes of Biotechnological Drugs of Plant Origin

A special issue of Processes (ISSN 2227-9717). This special issue belongs to the section "Pharmaceutical Processes".

Deadline for manuscript submissions: closed (10 November 2023) | Viewed by 4289

Special Issue Editors


E-Mail Website
Guest Editor
Department of Pharmacognosy, Faculty of Pharmacy and Biochemistry, University of Zagreb, 10000 Zagreb, Croatia
Interests: phytotherapy; phytochemistry; natural product chemistry; chromatography; extraction procedures; secondary metabolites
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Wroclaw Medical University, Borowska 211, 50-556 Wroclaw, Poland
Interests: plant biotechnology; plant in vitro cultures; plant physiology (oxidative stress, bio-elicitor response); molecular biology (gene expression level, elucidation of plant biosynthetic pathways); phytochemistry
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Biotechnologically derived drugs of plant origin serve as natural therapeutic products and a valuable alternative for synthetic drugs. The quality of such products is based not only on elucidating the biosynthesis pathways but also on highly precise synthesis and extraction processes. Due to a high variety of specialized metabolites, their production in plant material, derived from a number of plant species, is still under investigation. Similarly, new methods of extraction, separation, identification and isolation of these compounds are still being developed.

This Special Issue is dedicated to Synthesis and Extraction Processes of Biotechnological Drugs of Plant Origin, including, but not limited to, elucidation and utilization of biosynthetic pathways for production of valuable primary and secondary metabolites, methods for increasing the yield of their production, as well as their isolation from biological matrices and media.

Prof. Dr. Marijana Zovko Končić
Dr. Sylwia Zielińska
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biosynthesis
  • biosynthetic pathways
  • extraction procedures
  • medicinal plant
  • plant biotechnology
  • plant cell cultures
  • plant metabolites

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

16 pages, 1188 KiB  
Review
The Prospects of Algae-Derived Vitamins and Their Precursors for Sustainable Cosmeceuticals
by Neha Arora and George P. Philippidis
Processes 2023, 11(2), 587; https://doi.org/10.3390/pr11020587 - 15 Feb 2023
Cited by 10 | Viewed by 3873
Abstract
Aquatic algae are a rich source of a wide range of bioproducts intended to compete for a sizable global market share. Thanks to the gradual shift towards the use of natural products, microalgae-derived bioactive compounds offer an ecofriendly and vegan option to the [...] Read more.
Aquatic algae are a rich source of a wide range of bioproducts intended to compete for a sizable global market share. Thanks to the gradual shift towards the use of natural products, microalgae-derived bioactive compounds offer an ecofriendly and vegan option to the cosmeceutical sector, whose products aim to improve skin health but currently consist of mostly synthetic chemicals. In particular, algae-derived vitamins and their precursors are being explored and widely used in the cosmeceuticals industry as compounds that contain biologically active ingredients with therapeutic benefits. The present review highlights the current strategies for industrial production of an array of vitamins from algae for cosmeceutical applications. When compared to traditional plant sources, algae have been found to accumulate vitamins, such as A, B1, B2, B6, B12, C and E, in high concentrations. The purpose of this review is to provide context for the development of a green and sustainable algae-derived bioeconomy by summarizing and comparing the current market for vitamins and precursors derived from algae, as well as presenting novel strategies and key findings from the most recent research in this area. Emphasis is placed on novel biotechnological interventions that encompass genetic modifications, genetic engineering, and media development to enhance vitamin biosynthesis. Full article
Show Figures

Figure 1

Back to TopTop